"Pharmacogenetics of Cancer" - Cancer Drug Resistance special issue
- PMID: 35582607
- PMCID: PMC9090591
- DOI: 10.20517/cdr.2020.10
"Pharmacogenetics of Cancer" - Cancer Drug Resistance special issue
Conflict of interest statement
All authors declared that there are no conflicts of interest.
Similar articles
-
PREFACE for the special issue of xenobiotica on "pharmacogenetics of drug metabolism".Xenobiotica. 2020 Jan;50(1):1-2. doi: 10.1080/00498254.2019.1682716. Epub 2019 Oct 28. Xenobiotica. 2020. PMID: 31625424 No abstract available.
-
Pharmacogenetics and breast cancer management: current status and perspectives.Expert Opin Drug Metab Toxicol. 2015 May;11(5):719-29. doi: 10.1517/17425255.2015.1008447. Epub 2015 Feb 18. Expert Opin Drug Metab Toxicol. 2015. PMID: 25690018 Review.
-
An interview with Pharmacogenomics for the breast cancer special focus issue.Pharmacogenomics. 2012 Apr;13(6):655-8. doi: 10.2217/pgs.12.33. Pharmacogenomics. 2012. PMID: 22515608 No abstract available.
-
Pharmacogenetics of stomach cancer.Suppl Tumori. 2003 Sep-Oct;2(5):S19-22. Suppl Tumori. 2003. PMID: 12914384 Review.
-
Pharmacogenetics in Psychiatry.Pharmacopsychiatry. 2020 Jul;53(4):153-154. doi: 10.1055/a-1212-1101. Epub 2020 Jul 27. Pharmacopsychiatry. 2020. PMID: 32717764
Cited by
-
Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma.Cancers (Basel). 2023 May 13;15(10):2753. doi: 10.3390/cancers15102753. Cancers (Basel). 2023. PMID: 37345090 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources